X-77681592-C-T

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4BP6_ModerateBS2

The NM_000489.6(ATRX):​c.3664G>A​(p.Asp1222Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000149 in 1,206,487 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000015 ( 0 hom. 6 hem. )

Consequence

ATRX
NM_000489.6 missense

Scores

3
6
7

Clinical Significance

Likely benign criteria provided, single submitter U:2B:1

Conservation

PhyloP100: 6.25

Publications

6 publications found
Variant links:
Genes affected
ATRX (HGNC:886): (ATRX chromatin remodeler) The protein encoded by this gene contains an ATPase/helicase domain, and thus it belongs to the SWI/SNF family of chromatin remodeling proteins. This protein is found to undergo cell cycle-dependent phosphorylation, which regulates its nuclear matrix and chromatin association, and suggests its involvement in the gene regulation at interphase and chromosomal segregation in mitosis. Mutations in this gene are associated with X-linked syndromes exhibiting cognitive disabilities as well as alpha-thalassemia (ATRX) syndrome. These mutations have been shown to cause diverse changes in the pattern of DNA methylation, which may provide a link between chromatin remodeling, DNA methylation, and gene expression in developmental processes. Multiple alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2017]
ATRX Gene-Disease associations (from GenCC):
  • alpha thalassemia-X-linked intellectual disability syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • ATR-X-related syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • intellectual disability-hypotonic facies syndrome, X-linked, 1
    Inheritance: XL Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.37853667).
BP6
Variant X-77681592-C-T is Benign according to our data. Variant chrX-77681592-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 533627.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Hemizygotes in GnomAdExome4 at 6 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATRXNM_000489.6 linkc.3664G>A p.Asp1222Asn missense_variant Exon 9 of 35 ENST00000373344.11 NP_000480.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATRXENST00000373344.11 linkc.3664G>A p.Asp1222Asn missense_variant Exon 9 of 35 1 NM_000489.6 ENSP00000362441.4 P46100-1

Frequencies

GnomAD3 genomes
AF:
0.0000180
AC:
2
AN:
111119
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000378
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000167
AC:
3
AN:
179139
AF XY:
0.0000156
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000373
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000146
AC:
16
AN:
1095368
Hom.:
0
Cov.:
30
AF XY:
0.0000166
AC XY:
6
AN XY:
361092
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26262
American (AMR)
AF:
0.0000287
AC:
1
AN:
34831
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19258
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30128
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53276
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4124
European-Non Finnish (NFE)
AF:
0.0000178
AC:
15
AN:
841096
Other (OTH)
AF:
0.00
AC:
0
AN:
45975
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000180
AC:
2
AN:
111119
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
33341
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30633
American (AMR)
AF:
0.00
AC:
0
AN:
10449
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2633
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3564
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2619
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5914
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.0000378
AC:
2
AN:
52887
Other (OTH)
AF:
0.00
AC:
0
AN:
1501
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756
ExAC
AF:
0.0000330
AC:
4

ClinVar

Significance: Likely benign
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Alpha thalassemia-X-linked intellectual disability syndrome Uncertain:1Benign:1
Oct 28, 2019
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 11, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ATRX-related disorder Uncertain:1
Jun 12, 2024
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The ATRX c.3664G>A variant is predicted to result in the amino acid substitution p.Asp1222Asn. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0037% of alleles in individuals of European (Non-Finnish) descent in gnomAD, including one hemizygous individual. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.30
BayesDel_addAF
Benign
-0.046
T
BayesDel_noAF
Benign
-0.25
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.039
.;.;T;T
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.97
D;.;D;D
M_CAP
Pathogenic
0.40
D
MetaRNN
Benign
0.38
T;T;T;T
MetaSVM
Pathogenic
0.88
D
PhyloP100
6.2
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
-1.9
N;N;.;.
REVEL
Uncertain
0.46
Sift
Uncertain
0.0030
D;D;.;.
Sift4G
Uncertain
0.042
D;D;T;T
Polyphen
1.0
D;.;.;.
Vest4
0.30
MutPred
0.31
Gain of sheet (P = 0.1208);.;.;.;
MVP
0.92
MPC
0.19
ClinPred
0.43
T
GERP RS
5.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
gMVP
0.37
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs782520515; hg19: chrX-76937084; COSMIC: COSV64876077; COSMIC: COSV64876077; API